Overview

Effect of Febuxostat on Blood Pressure

Status:
Completed

Trial end date:
2014-08-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the effect of febuxostat, once daily (QD), compared to placebo on lowering ambulatory 24-hour mean blood pressure of participants with hypertension and hyperuricemia (not associated with gout).

Phase:

Phase 2

Details

Lead Sponsor:

Takeda

Treatments:

Febuxostat